Skip to main content
Clinical Trials/NCT03124082
NCT03124082
Unknown
Phase 4

Study Protocol "OFA: Opioid-Free Anesthesia".

University of Parma1 site in 1 country64 target enrollmentJanuary 4, 2017

Overview

Phase
Phase 4
Intervention
Remifentanil
Conditions
Postoperative Pain
Sponsor
University of Parma
Enrollment
64
Locations
1
Primary Endpoint
analgesic consumption
Last Updated
9 years ago

Overview

Brief Summary

Opioids have been used for analgesia since many years, but despite potent analgesia they are also associated to side effects, including opioid induced Hyperalgesia (OIH).

OIH in the surgical setting is debated, and may predispose patients to higher analgesic consumption in the preoperative period, and peripheral and central sensitization. The aim of the study is to compare remifentanil-based vs non opioid analgesia (clonidine, lidocaine, ketamine) for intraoperative management of patients undergoing laparoscopic left hemicolectomy, with the hypothesis that non- opiod treated patients will have lower morphine consumption in the first 24 hours after surgery. Peripheral and central hyperalgesia will be tested with Von Frey hairs and pin-prick to evaluate acute CNS (Central Nervous System) sensitization after surgery. Acute and persistent (1 and 3 months) pain will be registered, together with any side effect and parameters of surgical rehabilitation.

Registry
clinicaltrials.gov
Start Date
January 4, 2017
End Date
March 31, 2018
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Massimo Allegri

MD, Assistant Professor

University of Parma

Eligibility Criteria

Inclusion Criteria

  • left hemicolectomy
  • signed informed consent

Exclusion Criteria

  • \>90 ys \<18 ys
  • no consent
  • pregnancy
  • psychiatric disease
  • cardiac failure, aortic or mitral valve severe stenosis
  • kidney or hepatic failure
  • atrio-ventricular type II block
  • immunodepression
  • emergency surgery
  • ICU admittance

Arms & Interventions

opioid

remifentanil 0,15-0,25 mcg/kg/h

Intervention: Remifentanil

opioid free

ketamine bolus 0,5 mg/kg + infusion 0,25 mg/kg/h lidocaine bolus 1 mg/kg + infusion 1 mg/kg/h clonidine 4 mcg/kg

Intervention: Ketamine

opioid free

ketamine bolus 0,5 mg/kg + infusion 0,25 mg/kg/h lidocaine bolus 1 mg/kg + infusion 1 mg/kg/h clonidine 4 mcg/kg

Intervention: Lidocaine

opioid free

ketamine bolus 0,5 mg/kg + infusion 0,25 mg/kg/h lidocaine bolus 1 mg/kg + infusion 1 mg/kg/h clonidine 4 mcg/kg

Intervention: Clonidine

Outcomes

Primary Outcomes

analgesic consumption

Time Frame: 24 HOURS

morphine mg by PCA (Patient Controlled Analgesia)

Secondary Outcomes

  • peripheral sensitization(24 hours)
  • Pain Score on the Visual Analog Scale(3 months)
  • side effects(4 days after surgery)
  • central sensitization(24 hours)

Study Sites (1)

Loading locations...

Similar Trials